Genincode【GENI】銘柄情報

Genincode Plc (GENI) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.95

( - )

買値

0.90

売値

1.00

出来高

0.00

0.00 日の範囲 0.00

0.825 52 週間の範囲 5.25

時価総額

7.154M

前日終値

0.95

始値

時刻

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

6,814,345p

発行済株式数

753,041,137

配当利回り

PER

-0.46

1 株当たり利益 (EPS)

-0.02

歳入

3.08M

純利益

-5.71M

GENinCode Plc engages in the development and commercialization of clinical genetic tests for predictive analysis of risk to a patient’s health based on genes in the United Kingdom, Spain, Italy, the United States, Germany, and internationally. The company offers CARDIO inCode Score, a genetic test t... GENinCode Plc engages in the development and commercialization of clinical genetic tests for predictive analysis of risk to a patient’s health based on genes in the United Kingdom, Spain, Italy, the United States, Germany, and internationally. The company offers CARDIO inCode Score, a genetic test to evaluate the risk of coronary heart disease; LIPID inCode, a genetic test for the diagnosis of familial hypercholesterolemia with further coronary risk stratification of the patient; and SUDD inCode, a genetic diagnostic test for familial heart diseases, such as cardiomyopathies, channelopathies, and aortopathies related with sudden cardiac death syndrome. It also provides THROMBO inCode, a genetic test for the diagnosis of hereditary thrombophilia and for assessing the patient's risk of thrombosis; THROMBO inCode reproductive health, a genetic test that evaluates the impact of hereditary thrombophilia in patients with repeated miscarriages; and risk of ovarian cancer algorithm test product. In addition, the company is involved in Medical and scientific research activities. GENinCode Plc was incorporated in 2018 and is based in Manchester, the United Kingdom. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

www.genincode.com

本社

Manchester, United Kingdom

設立

2026

Genincode Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker GENI. The last closing price for Genincode was 0.95p. Over the last year, Genincode shares have traded in a share price range of 0.825p to 5.25p.

Genincode currently has 753,041,137 shares in issue. The market capitalisation of Genincode is £7.15 million. Genincode has a price to earnings ratio (PE ratio) of -0.46.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.05	5.55555555556	0.9	0.955	0.875	1373594	0.92114358	DE
4	-0.3	-24	1.25	1.25	0.825	5224108	0.97490657	DE
12	-0.15	-13.6363636364	1.1	1.375	0.825	6813475	1.1121406	DE
26	-1.45	-60.4166666667	2.4	2.45	0.825	5674369	1.13051882	DE
52	-1.3	-57.7777777778	2.25	5.25	0.825	3263272	1.43752882	DE
156	-11.05	-92.0833333333	12	13.5	0.825	1269806	1.90361494	DE
260	-47.55	-98.0412371134	48.5	48.5	0.825	814559	2.89168186	DE